We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare to Report Q2 Earnings: Key Estimates to Note
Read MoreHide Full Article
Key Takeaways
HCA is projected to report Q2 EPS of $6.14 and $18.46B in revenues, up 11.6% and 5.5%, respectively, YoY.
HCA's admissions, patient days and occupancy are all forecast to rise from the prior-year period.
Higher costs and a drop in outpatient surgeries may weigh on HCA's Q2 earnings performance.
Hospital operator HCA Healthcare, Inc. (HCA - Free Report) is set to report second-quarter 2025 results on July 25, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $6.14 per share on revenues of $18.46 billion.
The second-quarter earnings estimate remained stable over the past week. The bottom-line projection indicates an increase of 11.6% from the year-ago reported number. Also, the Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 5.5%.
Image Source: Zacks Investment Research
For 2025, the Zacks Consensus Estimate for HCA Healthcare’s revenues is pegged at $74.6 billion, implying a rise of 5.7% year over year. The consensus mark for 2025 EPS is pegged at $25.26, implying an increase of 15% year over year. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
HCA Healthcare has a robust history of surpassing earnings estimates, beating the consensus estimate in each of the last four quarters, with the average surprise being 7.1%. This is depicted in the figure below.
However, our proven model does not conclusively predict an earnings beat for HCA this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
HCA currently has an Earnings ESP of -8.77% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
What’s Shaping HCA Healthcare’s Q2 Results?
The Zacks Consensus Estimate for HCA Healthcare’s second-quarter equivalent admissions indicates 2.9% year-over-year growth, which aligns with our model estimate. The consensus mark for revenue per equivalent admission signals a 2.9% rise from a year ago.
The Zacks Consensus Estimate for equivalent patient days indicates 4.3% year-over-year growth. The consensus estimate for occupancy is pegged at 73.1%, up from 71.9% a year ago. While these factors are likely to have positioned HCA Healthcare for growth from the year-ago quarter, rising expenses and lower outpatient surgery cases make an earnings beat uncertain.
Our model estimate for second-quarter total operating expenses indicates a 6.5% increase from a year ago due to higher salaries, benefits and supply costs. We expect supply costs to jump 5.3% in the to-be-reported quarter.
The consensus estimate for outpatient surgery cases indicates a 2.2% year-over-year decline. Also, we expect the average length of stay to decline 1.4% from the year-ago period.
Stocks That Warrant a Look
While an earnings beat looks uncertain for HCA Healthcare, here are some companies from the broader Medical space that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around:
The Zacks Consensus Estimate for Cencora’s bottom line for the to-be-reported quarter signals a 13.2% improvement from a year ago. Cencora beat earnings estimates in all of the past four quarters, with an average surprise of 6%.
Tenet Healthcare Corp (THC - Free Report) has an Earnings ESP of +6.68% and carries a Zacks Rank #3 at present.
The Zacks Consensus Estimate for Tenet Healthcare’s bottom line for the to-be-reported quarter signals a 22.9% improvement from a year ago. Tenet Healthcare beat earnings estimates in all of the past four quarters, with an average surprise of 26.4%.
Davita Inc (DVA - Free Report) has an Earnings ESP of +6.67% and currently carries a Zacks Rank #3.
The Zacks Consensus Estimate for Davita’s bottom line for the to-be-reported quarter signals a 4.3% improvement from a year ago. Davita beat earnings estimates in three of the past four quarters, with an average surprise of 3.6%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
HCA Healthcare to Report Q2 Earnings: Key Estimates to Note
Key Takeaways
Hospital operator HCA Healthcare, Inc. (HCA - Free Report) is set to report second-quarter 2025 results on July 25, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $6.14 per share on revenues of $18.46 billion.
The second-quarter earnings estimate remained stable over the past week. The bottom-line projection indicates an increase of 11.6% from the year-ago reported number. Also, the Zacks Consensus Estimate for quarterly revenues suggests year-over-year growth of 5.5%.
Image Source: Zacks Investment Research
For 2025, the Zacks Consensus Estimate for HCA Healthcare’s revenues is pegged at $74.6 billion, implying a rise of 5.7% year over year. The consensus mark for 2025 EPS is pegged at $25.26, implying an increase of 15% year over year. (See the Zacks Earnings Calendar to stay ahead of market-making news.)
HCA Healthcare has a robust history of surpassing earnings estimates, beating the consensus estimate in each of the last four quarters, with the average surprise being 7.1%. This is depicted in the figure below.
HCA Healthcare, Inc. Price and EPS Surprise
HCA Healthcare, Inc. price-eps-surprise | HCA Healthcare, Inc. Quote
Q2 Earnings Whispers for HCA Healthcare
However, our proven model does not conclusively predict an earnings beat for HCA this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
HCA currently has an Earnings ESP of -8.77% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
What’s Shaping HCA Healthcare’s Q2 Results?
The Zacks Consensus Estimate for HCA Healthcare’s second-quarter equivalent admissions indicates 2.9% year-over-year growth, which aligns with our model estimate. The consensus mark for revenue per equivalent admission signals a 2.9% rise from a year ago.
The Zacks Consensus Estimate for equivalent patient days indicates 4.3% year-over-year growth. The consensus estimate for occupancy is pegged at 73.1%, up from 71.9% a year ago. While these factors are likely to have positioned HCA Healthcare for growth from the year-ago quarter, rising expenses and lower outpatient surgery cases make an earnings beat uncertain.
Our model estimate for second-quarter total operating expenses indicates a 6.5% increase from a year ago due to higher salaries, benefits and supply costs. We expect supply costs to jump 5.3% in the to-be-reported quarter.
The consensus estimate for outpatient surgery cases indicates a 2.2% year-over-year decline. Also, we expect the average length of stay to decline 1.4% from the year-ago period.
Stocks That Warrant a Look
While an earnings beat looks uncertain for HCA Healthcare, here are some companies from the broader Medical space that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around:
Cencora, Inc. (COR - Free Report) has an Earnings ESP of +1.49% and currently carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Cencora’s bottom line for the to-be-reported quarter signals a 13.2% improvement from a year ago. Cencora beat earnings estimates in all of the past four quarters, with an average surprise of 6%.
Tenet Healthcare Corp (THC - Free Report) has an Earnings ESP of +6.68% and carries a Zacks Rank #3 at present.
The Zacks Consensus Estimate for Tenet Healthcare’s bottom line for the to-be-reported quarter signals a 22.9% improvement from a year ago. Tenet Healthcare beat earnings estimates in all of the past four quarters, with an average surprise of 26.4%.
Davita Inc (DVA - Free Report) has an Earnings ESP of +6.67% and currently carries a Zacks Rank #3.
The Zacks Consensus Estimate for Davita’s bottom line for the to-be-reported quarter signals a 4.3% improvement from a year ago. Davita beat earnings estimates in three of the past four quarters, with an average surprise of 3.6%.